Objectives There is interest in doxycycline as prophylaxis against sexually transmitted
infections (STIs), but concern about antimicrobial resistance (AMR). We conducted a …

There is considerable interest in the use of doxycycline post exposure prophylaxis (PEP) to
reduce the incidence of bacterial sexually transmitted infections (STIs). An important concern …

In 2017, BASHH and Public Health England, now the UK Health Security Agency (UKHSA),
published a position statement on the use of doxycycline as prophylaxis for STIs. 1 It advised …

Rates of sexually transmitted infections (STIs) continue to rise across the world and
interventions are essential to reduce their incidence. Past and recent studies have indicated …

Doxycycline is a second-generation tetracycline, available worldwide for half a century. It is
an inexpensive broad-spectrum antimicrobial agent largely used in the management of …

Background Sexually transmitted infections (STIs) such as syphilis, gonorrhea, and
chlamydia have significantly increased over the past decade in the United States …

Despite their high global incidence, sexually transmitted infections (STIs) remain a
neglected area of research. Increased rates of STIs have been reported in particular among …

Background Interventions to reduce sexually transmitted infections (STIs) among men who
have sex with men (MSM) are needed. Methods We conducted an open-label, randomized …

Bacterial sexually transmitted infections (STIs) have been increasing over the past 2
decades in gay, bisexual, and other men who have sex with men. With the widespread use …

Background Doxycycline postexposure prophylaxis (PEP) has been shown to prevent
sexually transmitted infections (STIs) among cisgender men and transgender women, but …